
Mandar A. Aras MD PhD
Heart Failure & Transplantation
Associate Professor
Join to view full profile
505 Parnassus AveSan Francisco, CA 94143
Dr. Aras is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mandar Aras, MD, PhD is a Cardiologist based in San Francisco, CA. He has subspecialized in Heart Failure & Transplantation, and focuses on infiltrative, inflammatory, and genetic cardiomyopathy.
Education & Training
University of California (San Francisco) School of MedicineFellowship, Heart Failure, Heart Transplant, and Pulmonary Hypertension, 2017 - 2018
University of California (San Francisco)Fellowship, Cardiovascular Disease, 2014 - 2017
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
University of Pittsburgh School of MedicineClass of 2011, MD, PhD
Certifications & Licensure
CA State Medical License 2014 - 2027
NC State Medical License 2011 - 2014
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Tafamidis: is it truly a game changer for transthyretin amyloid cardiomyopathy?Sarena Yang, Justin Hyun, Mandar A Aras
Indian Pacing and Electrophysiology Journal. 2026-10-06 - Lessons Learned from the HVAD Post-Approval Study Registry: Implications for Investigating Future Ventricular Assist Device Technology.Jennifer A Cowger, Igor D Gregoric, Liviu Klein, Duc Thinh Pham, Michael S Kiernan
Journal of Cardiac Failure. 2026-10-01 - Incidence and diagnostic yield of repeat imaging-based screening for hepatic arteriovenous malformations in patients with HHT.Benjamin Cho, Leena Usman, Torianna Lomax Truong, Darcy Phelan, Debajyoti Datta
Hepatology Communications. 2026-08-01
Press Mentions
Cardiac Echo Tracks Checkpoint Inhibitor DamageFebruary 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: